via Instapundit:
Novel monoclonal antibody targets deadly sepsis by preventing 'cytokine storms'
Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal antibody to stop sepsis, a deadly full-body infection. The antibody also has the potential to treat a broad array of other inflammatory conditions, including autoimmune disorders, their research indicates.
,,,,Ma and his collaborators' new antibody, they hope, could become the first treatment that directly targets the underlying immune system dysregulation responsible for sepsis. It seeks to prevent the "cytokine storms" that made headlines in the pandemic, shutting down the body's hyperactive immune response before organ damage can occur.
very early research and now will go into reality i.e. clinical trials.
No comments:
Post a Comment